Coverage with evidence development (CED)
Coverage with evidence development (CED) is a CMS approach that pays for a promising but not fully proven item or service only when the patient participates in approved data collection or a study. It links reimbursement to building the evidence base.
What is coverage with evidence development (CED)?
Coverage with evidence development (CED) is a policy mechanism used by the Centers for Medicare & Medicaid Services (CMS) to pay for an item or service that shows promise but lacks definitive proof of benefit. Rather than denying coverage outright or approving it without conditions, CMS agrees to reimburse it only when the patient is enrolled in an approved registry, study, or data-collection effort.
The arrangement ties payment to the generation of evidence, so each covered case contributes data on real-world outcomes. Over time that accumulated information can support a fuller coverage decision, either confirming the value of the service or revealing that it does not deliver the expected benefit.
Why does CED matter for payers and patients?
CED gives patients earlier access to emerging technologies that might otherwise wait years for coverage, while protecting the program from paying open-endedly for interventions of uncertain value. It strikes a middle path between blanket approval and outright denial.
For the evidence ecosystem, CED converts routine clinical use into a structured learning opportunity, filling gaps that traditional trials may leave open. The result is a coverage decision grounded in data drawn from the actual Medicare population rather than narrow study cohorts.
- ced meaning
- what is coverage with evidence development
- cms coverage with evidence development
- ced medicare
- coverage with evidence development policy
- ced reimbursement